Darunavir 600 and 800 mg
- Product NDC
- 69097-244
- 11-digit product format
- 690970244
- Labeler code
- 69097
- Product ID
- 69097-244_e3d4803e-30b2-4c8b-90e3-b04c2da4b1c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- darunavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA206288
- Marketing category
- ANDA
- Marketing start
- 2023-11-29
- Substance
- DARUNAVIR HYDRATE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Darunavir 600 and 800 mg
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DARUNAVIR HYDRATE | 800 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | KPC4NRB25L |
| Rxcui | 670026, 1359269 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 81157882-d7f5-4b49-9a52-b2a0c7e54020 | Product name | 2 | 20260107 |
| 12fd8c59-0b3a-2882-9cdb-92782ec03e2f | Product name | 6 | 20251113 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| a56d673d-fa42-4b0e-b5ce-e65a5eab34b7 | Product name | 1 | 20180911 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69097-244-02 | Darunavir 600 and 800 mg | 30 in 1 BOTTLE | TABLET | 30 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 670026 | darunavir 600 MG Oral Tablet | PSN | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 1359269 | darunavir 800 MG Oral Tablet | PSN | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 670026 | darunavir 600 MG Oral Tablet | SCD | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 1359269 | darunavir 800 MG Oral Tablet | SCD | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 670026 | darunavir (as darunavir ethanolate) 600 MG Oral Tablet | SY | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 1359269 | darunavir (as darunavir ethanolate) 800 MG Oral Tablet | SY | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 670026 | darunavir (as darunavir hydrate) 600 MG Oral Tablet | SY | 5624cc30-d484-458e-b234-9bb745a118ca | 3 |
| 670026 | darunavir 600 MG Oral Tablet | PSN | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 1359269 | darunavir 800 MG Oral Tablet | PSN | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 670026 | darunavir 600 MG Oral Tablet | SCD | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 1359269 | darunavir 800 MG Oral Tablet | SCD | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 670026 | darunavir (as darunavir ethanolate) 600 MG Oral Tablet | SY | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 1359269 | darunavir (as darunavir ethanolate) 800 MG Oral Tablet | SY | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 670026 | darunavir (as darunavir hydrate) 600 MG Oral Tablet | SY | 632293b0-d220-444e-8a5b-2ee8c225b66d | 2 |
| 1359269 | darunavir 800 MG Oral Tablet | PSN | bf99d8b8-c4e0-4cb4-924e-8cdcfd8d1aa1 | 1 |
| 1359269 | darunavir 800 MG Oral Tablet | SCD | bf99d8b8-c4e0-4cb4-924e-8cdcfd8d1aa1 | 1 |
| 1359269 | darunavir (as darunavir ethanolate) 800 MG Oral Tablet | SY | bf99d8b8-c4e0-4cb4-924e-8cdcfd8d1aa1 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69097-244-02 | 69097024402 | 30 TABLET in 1 BOTTLE (69097-244-02) | 30 tablet | 2023-11-29 | No | No | Current |